Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the phase 3 SOLO studies

SOLO I and SOLO II Investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the phase 3 SOLO studies'. Together they form a unique fingerprint.

Medicine & Life Sciences